Results 21 to 30 of about 6,917,354 (302)

Nuclear Medicine Status in Egypt: Our Beginnings and Where We Are Now . [PDF]

open access: yesEgyptian Journal of Nuclear Medicine
Nuclear medicine began to take shape in the early 20th century with the discovery of radioactivity and has since grown into a crucial important medical specialty that uses radioisotopes for imaging, diagnosis, and treatment in health care [1].
Mai Elahmadawy, Hosna Moustafa
doaj   +1 more source

Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer

open access: yes, 2023
The impact of chemotherapy on brain functionality has been widely investigated from a clinical perspective, and there is a consensus on a significant impairment of multiple cognitive domains affecting cancer patients after treatment.
Schillaci, Orazio   +11 more
core   +1 more source

Tumor Hypoxia Imaging Agents in Nuclear Medicine

open access: yesTrends in Peptide and Protein Sciences, 2017
Hypoxia is due to imbalance in oxygen supply and oxygen demand compromising biological functions of cells. Since tumor hypoxia results in angiogenesis, apoptosis, metastasis, tumor aggressiveness and treatment failure, in vivo measurement is required ...
Mahtab Mohammadpour, Soraya Shahhosseini
doaj   +1 more source

Nuclear investigative techniques and their interpretation in the heart and vascular disease

open access: yesAnnals of Cardiac Anaesthesia, 2020
Over the last several decades, myocardial perfusion imaging with single photon emission tomography and positron emission tomography has been a mainstay for the evaluation of patients with known or suspected coronary artery disease non-invasively ...
Manish Ora, Sanjay Gambhir
doaj   +1 more source

Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent

open access: yesFrontiers in Endocrinology, 2021
IntroductionThyroid cancer is the main endocrine neoplasia worldwide, for which 131I therapy is the cornerstone treatment. One of the main problems of follow up in patients with this type of cancer, is the need for thyroglobulin stimulation, not to ...
Quetzali Pitalua-Cortes   +7 more
doaj   +1 more source

Visual demonstration of aliasing in planar nuclear medicine imaging: The importance of correct collimator selection by nuclear medicine practitioners Radiography [PDF]

open access: yes, 2019
Aliasing artefact is an imaging distortion phenomenon experienced in a wide variety of medical imaging modalities. This case report illustrates its occurrence during planar gamma camera nuclear medicine imaging under non-clinical conditions using ...
Elliott, J.   +3 more
core   +1 more source

KSNM 60 in General Nuclear Medicine: the Old Dream Comes True

open access: yes, 2022
Since the establishment of the Korean Society of Nuclear Medicine (KSNM) in 1961 by Professor Munho Lee, the KSNM has been progressing in various medical fields.
Jin-Sook Ryu, Won Woo Lee
core   +1 more source

Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT

open access: yesCancer Imaging, 2022
This review describes the main benefits of using long axial field of view (LAFOV) PET in clinical applications. As LAFOV PET is the latest development in PET instrumentation, many studies are ongoing that explore the potentials of these systems, which ...
Joyce van Sluis   +11 more
doaj   +1 more source

Very-Low-Dose Radiation and Clinical Molecular Nuclear Medicine

open access: yesLife, 2022
Emerging molecular and precision medicine makes nuclear medicine a de facto choice of imaging, especially in the era of target-oriented medical care.
Chi-Jung Tsai   +7 more
doaj   +1 more source

Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment

open access: yes, 2011
Radiolabeled peptides have been an important class of compounds in radiopharmaceutical sciences and nuclear medicine for more than 20 years. Despite strong research efforts, only somatostatin-based radiopeptides have a real impact on patient care ...
Helmut R. Maecke   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy